NDC 50090-6706-00 - HADLIMA
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50090-6706
- Requested NDC
- 50090-6706-00
- Package NDCs from labels
- 50090-6706-0, 50090-6706-00
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2026-10-28
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| HADLIMA - A-S Medication Solutions | A-S Medication Solutions | 2026-10-28 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-6706-0 | HADLIMA | 1 mL in 1 CARTON | SOLUTION | 1 | 1 | |
| 50090-6706-0 | HADLIMA | 2 in 1 CARTON | SOLUTION | 2 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50090-6706 | HADLIMA (ADALIMUMAB-BWWD) SOLUTION [A-S MEDICATION SOLUTIONS] | 1 | Current NDC, 2 package rows | 20231003_ef25af7e-6267-409a-8d68-de51eb48812a.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| QUALITY CHOICE Nausea Relief | SODIUM CITRATE DIHYDRATE | QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION) | d89e41c1-399a-4157-8d54-bfefe3b1c1cd | 2026-10-28 | Warnings | B22547B95K |
| HADLIMA | ADALIMUMAB-BWWD | A-S Medication Solutions | ef25af7e-6267-409a-8d68-de51eb48812a | 2026-10-28 | Boxed warning, Warnings, Adverse reactions | BLA761059 50090-6706-0 50090-6706 50090670600 2640300 2640287 d1231e35-c343-462b-9711-45a61f6a209c ef25af7e-6267-409a-8d68-de51eb48812a FYS6T7F842 |
| HADLIMA | ADALIMUMAB-BWWD | A-S Medication Solutions | f7f9da92-ff5d-4260-b4bd-e3f6993a36ae | 2026-10-27 | Boxed warning, Warnings, Adverse reactions | BLA761059 2640300 2640287 FYS6T7F842 |
| AQUACETIC-30 | CLEANING SOLUTION FOR HEMODIALYSIS MACHINES | Aqua Medica, S.A. de C.V. | 040775ab-41bd-cd36-e063-6394a90a08aa | 2026-10-16 | Warnings | 2968PHW8QP |
| CITRACID-50 | DESINFECTANT SOLUTION FOR HEMODIALYSIS MACHINE | Aqua Medica, S.A. de C.V. | 040713e7-67cd-8eb0-e063-6394a90aa2a9 | 2026-10-16 | Warnings | 2968PHW8QP |
| YUSIMRY | ADALIMUMAB-AQVH | Meitheal Pharmaceuticals Inc. | 4cab600d-6950-409f-a6d8-d447da22cd95 | 2026-10-12 | Boxed warning, Warnings, Adverse reactions | FYS6T7F842 |
| Sal De Uvas Picot | CITRIC ACID MONOHYDRATE, SODIUM BICARBONATE | Navajo Manufacturing Company Inc. | ff6ac79d-564d-4abf-83c7-b01751249c7f | 2026-10-09 | Warnings | 2968PHW8QP |
| Sal de Uvas Picot | CITRIC ACID MONOHYDRATE AND SODIUM BICARBONATE | Navajo Manufacturing Company Inc. | 5d6d297d-770b-dd9f-e063-6294a90a4bb8 | 2026-10-02 | Warnings | 2968PHW8QP |
| Emetrol Chewables | SODIUM CITRATE DIHYDRATE | WellSpring Pharmaceutical Corporation | 9880a18a-cf84-47cd-99b5-d692065a25bf | 2026-09-24 | Warnings | B22547B95K |
| TrophAmine | ISOLEUCINE, LEUCINE, LYSINE ACETATE, METHIONINE, PHENYLALANINE, THREONINE, TRYPTOPHAN, VALINE, CYSTEINE HYDROCHLORIDE, HISTIDINE, TYROSINE, N-ACETYL-TYROSINE, ALANINE, ARGININE, PROLINE, SERINE, GLYCINE, ASPARTIC ACID, GLUTAMIC ACID, AND TAURINE | B. Braun Medical Inc. | cb6d23ff-3ec5-445a-acbe-f88fd57949bf | 2026-08-19 | Warnings, Adverse reactions | 4QD397987E |
| CVS Health Nausea Relief | SODIUM CITRATE DIHYDRATE | CVS PHARMACY,INC. | a5f9de6f-70d8-4bb0-8a5b-3dd120df2990 | 2026-08-14 | Warnings | B22547B95K |
| Metabatone | ARALIA RACEMOSA, AVENA SATIVA, BERBERIS VULGARIS, CAPSICUM ANNUUM, GINKGO BILOBA, PHYTOLACCA DECANDRA, HYPOTHALAMUS SUIS, ADENOSINUM TRIPHOSPHORICUM DINATRUM, ALPHA-KETOGLUTARICUM ACIDUM, FEL TAURI, HYALURONIDASE, PANCREAS SUIS, PANCREATINUM, PAPAIN, STOMACH (SUIS), L-ALANINE, L- ARGININE, L-CARNITINE, CYSTEINUM, L-GLUTAMINE, L-HISTIDINE, L-ISOLEUCINE, L-LEUCINE, L-LYSINE, L-METHIONINE, L-ORNITHINE, L-PROLINE, L-SERINE, L-TRYPTOPHAN, L-TYROSINE, L-VALINE, CALCAREA CARBONICA, CALCAREA PHOSPHORICA, IODIUM, | Energique, Inc. | 9510bb76-b717-407d-b9e8-da7743e4cfc8 | 2026-07-31 | Warnings | 4QD397987E |
| IDkit HP ONE | CITRIC ACID ANHYDROUS AND 13C UREA | Meridian Bioscience Israel Ltd | 8baab7a7-5d20-46ad-9c4a-762992ef6b51 | 2026-07-28 | Warnings, Adverse reactions | 2968PHW8QP |
| AMJEVITA | ADALIMUMAB-ATTO | Amgen USA Inc. | b7178e36-6787-45ab-8fee-be59bc6a4aa4 | 2026-07-13 | Boxed warning, Warnings, Adverse reactions | FYS6T7F842 |
| AMJEVITA | ADALIMUMAB-ATTO | Amgen, Inc | 9c44bd5b-4464-40a4-8933-8680950f00f2 | 2026-06-25 | Boxed warning, Warnings, Adverse reactions | FYS6T7F842 |
| AMJEVITA | ADALIMUMAB-ATTO | Nuvaila Limited | d7862491-2634-4402-b001-dcc1abf8dd58 | 2026-06-25 | Boxed warning, Warnings, Adverse reactions | FYS6T7F842 |
| Chemstat | GLYCERINUM, TARAXACUM OFFICINALE, PHYTOLACCA DECANDRA, ARSENICUM ALBUM, BOVISTA, CARBO VEGETABILIS, CARBONEUM SULPHURATUM, COFFEA CRUDA, NITRICUM ACIDUM, NUX VOMICA, PETROLEUM, PHOSPHORICUM ACIDUM, PHOSPHORUS, SULPHUR, ACETYLSALICYLICUM ACIDUM, FORMALINUM, GLONOINUM, INSULINUM (HUMAN), LITHIUM CARBONICUM, TEREBINTHINA, THYROIDINUM (SUIS), ACETICUM ACIDUM, BENZOICUM ACIDUM, BENZYL ALCOHOL, BORICUM ACIDUM, CHLORINUM, CORTISONE ACETICUM, EUGENOL, FOLLICULINUM, ISOPROPYL PALMITATE, LACTICUM ACIDUM, | Energique, Inc. | 2e361b50-9268-4053-b13c-93af64549848 | 2026-06-25 | Warnings | 506T60A25R |
| Leukotrap WB System | CPDA-1 BLOOD BAG COLLECTION SYSTEM | GVS TM INC | 54fd8a72-0527-df0c-e063-6294a90abe75 | 2026-06-24 | 2968PHW8QP | |
| Leukotrap WB System | CPDA-1 BLOOD BAG COLLECTION SYSTEM | GVS TM INC | 54fddca1-b40c-7af0-e063-6294a90a410e | 2026-06-24 | 2968PHW8QP | |
| Leukotrap WB System | CPDA-1 BLOOD BAG COLLECTION SYSTEM | GVS TM INC | 54fdf83e-f641-1f69-e063-6394a90ab750 | 2026-06-24 | 2968PHW8QP |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.